Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W HENLE

Showing results (211-220 of 244) with videos related to

Pageof 25
Sort By:
Infection|January 1, 1987
Acyclovir treatment in infectious mononucleosis: a clinical and virological studyJ Andersson, B Sköldenberg, W Henle, et al.
The Journal of Infectious Diseases|July 1, 1987
Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infectionG Miller, E Grogan, D Rowe, et al.
The American Journal of Medicine|December 1, 1977
Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 casesC A Horwitz, W Henle, G Henle, et al.
The New England Journal of Medicine|March 21, 1985
Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transferG Miller, E Grogan, D K Fischer, et al.
Journal of the National Cancer Institute|May 1, 1977
Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in UgandaC L Olweny, I Atine, A Kaddu-Mukasa, et al.
Clinical Immunology and Immunopathology|December 1, 1986
Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cellsR Szigeti, L Timar, O Weiland, et al.
Journal of the National Cancer Institute|January 1, 1978
Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remissionP Gunvén, G Klein, J L Ziegler, et al.
Cancer Research|March 1, 1984
Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigensG Masucci, H Mellstedt, M G Masucci, et al.
Journal of Clinical Immunology|September 1, 1984
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patientsG Masucci, I Berkel, M G Masucci, et al.
American Journal of Clinical Pathology|August 1, 1988
Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virusT A Steeper, C A Horwitz, M Hanson, et al.
Pageof 25

Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
Infection|January 1, 1987
Acyclovir treatment in infectious mononucleosis: a clinical and virological studyJ Andersson, B Sköldenberg, W Henle, et al.
The Journal of Infectious Diseases|July 1, 1987
Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infectionG Miller, E Grogan, D Rowe, et al.
The American Journal of Medicine|December 1, 1977
Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 casesC A Horwitz, W Henle, G Henle, et al.
The New England Journal of Medicine|March 21, 1985
Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transferG Miller, E Grogan, D K Fischer, et al.
Journal of the National Cancer Institute|May 1, 1977
Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in UgandaC L Olweny, I Atine, A Kaddu-Mukasa, et al.
Clinical Immunology and Immunopathology|December 1, 1986
Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cellsR Szigeti, L Timar, O Weiland, et al.
Journal of the National Cancer Institute|January 1, 1978
Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remissionP Gunvén, G Klein, J L Ziegler, et al.
Cancer Research|March 1, 1984
Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigensG Masucci, H Mellstedt, M G Masucci, et al.
Journal of Clinical Immunology|September 1, 1984
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patientsG Masucci, I Berkel, M G Masucci, et al.
American Journal of Clinical Pathology|August 1, 1988
Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virusT A Steeper, C A Horwitz, M Hanson, et al.
Pageof 25